US-India interim trade deal extends tariff shield for Indian pharma, with riders
The India-US joint statement highlights the provisional exclusion of Indian pharmaceutical exports comprising generic drugs including antibiotics, vaccines, bulk drugs and intermediates, from reciprocal tariffs but it is subject to the successful conclusion of the interim agreement
The India-US joint statement highlights the provisional exclusion of Indian pharmaceutical exports comprising generic drugs including antibiotics, vaccines, bulk drugs and intermediates, from reciprocal tariffs but it is subject to the successful conclusion of the interim agreement
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
